StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $41.65MP/E –Yield –

CalciMedica operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CalciMedica's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.11M. For fiscal 2025 it was -$21.18M. The highest annual figure on record is -$11.76M in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.18M–
FY2024Dec 31, 2024-$21.15M–
FY2023Dec 31, 2023-$25.73M–
FY2022Dec 31, 2022-$11.76M–
FY2021Dec 31, 2021-$31.50M–
FY2020Dec 31, 2020-$32.06M–
FY2019Dec 31, 2019-$31.22M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.62M–
Q1 FY2026Mar 31, 2026-$4.86M–
Q4 FY2025Dec 31, 2025-$4.85M–
Q3 FY2025Sep 30, 2025-$4.78M–
Q2 FY2025Jun 30, 2025-$6.67M–
Q1 FY2025Mar 31, 2025-$4.88M–
Q4 FY2024Dec 31, 2024-$4.97M–
Q3 FY2024Sep 30, 2024-$4.67M–
Q2 FY2024Jun 30, 2024-$6.79M–
Q1 FY2024Mar 31, 2024-$4.72M–
Q4 FY2023Dec 31, 2023-$3.61M–
Q3 FY2023Sep 30, 2023-$4.57M–
Q2 FY2023Jun 30, 2023-$12.19M–
Q1 FY2023Mar 31, 2023-$5.36M–
Q2 FY2022Jun 30, 2022-$2.22M–
Q1 FY2022Mar 31, 2022-$3.63M–
Q4 FY2021Dec 31, 2021-$8.96M–
Q3 FY2021Sep 30, 2021-$5.50M–
Q2 FY2021Jun 30, 2021-$7.78M–
Q1 FY2021Mar 31, 2021-$9.26M–
Q4 FY2020Dec 31, 2020-$9.77M–
Q3 FY2020Sep 30, 2020-$5.36M–
Q2 FY2020Jun 30, 2020-$6.22M–
Q1 FY2020Mar 31, 2020-$10.71M–
Q4 FY2019Dec 31, 2019-$9.87M–

More CalciMedica figures

See a number that looks wrong?